Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ DEFICIT (Unaudited)

v3.10.0.1
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ DEFICIT (Unaudited) - 9 months ended Sep. 30, 2018 - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2017 246,660,367 246,660,367    
Beginning balance at Dec. 31, 2017 $ (5,518) $ 25 $ 801,787 $ (807,330)
Increase (Decrease) in Stockholders' Equity        
Common stock issued in connection with exercise of stock options (in shares)   1,376,934    
Common stock issued in connection with exercise of stock options 434   434  
Stock based compensation expense 9,178   9,178  
Net loss for the period $ (100,338)     (100,338)
Ending balance (in shares) at Sep. 30, 2018 248,037,301 248,037,301    
Ending balance at Sep. 30, 2018 $ (96,244) $ 25 $ 811,399 $ (907,668)